Russia denies Brazilian refusal to urgently register Sputnik V vaccine

Reacting to some publications about Brazil’s refusal to urgently register the Sputnik V vaccine, the Russian Direct Investment Fund (RFPI) said on January 17 that Brazilian authorities had requested data to be provided to them. additional, a “standard procedure”.

–

The Russian Direct Investment Fund (RFPI) on January 17 denied Brazil’s refusal to carry out emergency registration of the anti-Covid Sputnik V vaccine, information relayed by a number of media.

Brazilian health authorities have indeed requested additional data about the drug:

“Following the appearance in some media of a fake news concerning the refusal of emergency registration of the Sputnik V vaccine in Brazil, we inform that the Brazilian Health Vigilance Agency (Anvisa) has requested additional data on the Sputnik V vaccine, which will be provided to him initially ”, indicates the organization.

A standard approach

Requesting additional information is standard procedure and does not mean denial of registration, the Russian Direct Investment Fund said. The Brazilian Congress had already approved the law currently being studied by the Senate, which would allow the vaccine to be used throughout the country.

“We also draw the attention of media representatives to the fact that fake news is knowingly relayed overnight and on weekends as part of a disinformation campaign to hinder the process of its verification. The RFPI press service is open 24/7 and asks journalists to check information before publication to avoid spreading fake news, ”the Russian Direct Investment Fund reported.

The reason for this comment

This statement is made in response to information released by Reuters on the referral by the Brazilian Health Vigilance Agency of documents relating to the approval of the emergency use of the Sputnik V vaccine, submitted by Uniao Quimica, a Brazilian pharmaceutical company .

Previously, the RFPI had denied the Reuters article on Hungary’s decision to forgo Sputnik V in favor of other vaccines using EU procurement mechanisms or coming directly from China. The agency referred to the head of the administration of the Hungarian Prime Minister. The RFPI called it “yet another example of fake news in reputable media”.

Approved in Russia in August, the Sputnik V vaccine is already registered in Serbia, Argentina, Belarus, Algeria, Bolivia, Palestine, Venezuela and Paraguay. Its registration is expected next week in two other countries.

– .